Publications by authors named "Ruizhe Gao"

The heat shock protein (HSP) 110 family has a key role as a unique class of molecular chaperones maintaining cellular proteostasis in eukaryotes. Abnormal activation of Hsp110 has been implicated in several diseases. Given its important role in pathogenesis, Hsp110 has become a novel drug target for disease diagnosis and targeted therapy.

View Article and Find Full Text PDF

Breast cancer, a leading cause of cancer-related mortality in women, is characterized by its propensity for metastasis. Heat shock protein 110 (Hsp110), a molecular chaperone encoded by the HSPH1 gene, has been implicated in cancer progression, including breast cancer, where it is upregulated and associated with worse outcomes. However, the role of Hsp110 in breast cancer pathogenesis and its potential as a therapeutic target have not been thoroughly investigated.

View Article and Find Full Text PDF

Pulmonary arterial hypertension (PAH) is a progressive and fatal cardiovascular disorder that is characterized by pulmonary vascular remodeling. Our previous results demonstrated that heat shock protein (Hsp110) was significantly activated to induce vascular remodeling by enhancing the Hsp110-STAT3 interaction. The development of inhibitors that disrupt this association represents a novel strategy for the treatment of PAH.

View Article and Find Full Text PDF
Article Synopsis
  • - The heat shock protein 110 (Hsp110) family is crucial in keeping cells healthy by helping proteins maintain their proper structure and function.
  • - Hsp110s can work independently or assist other chaperones, and problems with Hsp110s are linked to various diseases, suggesting they could be important drug targets.
  • - This review highlights the understanding of Hsp110s in disease and explores their potential as targets for new therapeutic strategies and diagnostics.
View Article and Find Full Text PDF

Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disorder marked by vascular remodeling, which is linked to the malignant phenotypes of pulmonary vascular cells. The prevailing therapeutic approaches for PAH tend to neglect the potential role of vascular remodeling, leading to the clinical prognosis remains poor. Previously, we first demonstrated that heat shock protein (Hsp110) was significantly activated to boost Hsp110-STAT3 interaction, which resulted in abnormal proliferation and migration of human pulmonary arterial endothelial cells (HPAECs) under hypoxia.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers are focusing on dual-target agents that can help treat pulmonary arterial hypertension (PAH) by improving blood vessel dilation and reducing vascular remodeling.
  • The study identified a compound from their library that inhibits the heat shock protein 110 (Hsp110) and enhances soluble guanylate cyclase (sGC) activity, leading to the design of new bisamide derivatives.
  • One of these derivatives showed better performance than a commonly used drug, riociguat, in reducing vascular issues and heart enlargement in rat models of hypoxia-induced PAH, indicating a promising new approach for treatment.
View Article and Find Full Text PDF

China's population is ageing, affecting trends in social development and basic national conditions. More attention must be paid to the lack of care needs assessments for the elderly in China's pension institutions. This paper discusses a systematic evaluation of the care needs of the elderly in China's elderly care institutions.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ruizhe Gao"

  • Ruizhe Gao's recent research primarily focuses on the role of heat shock protein 110 (Hsp110) in the pathology of pulmonary arterial hypertension (PAH), highlighting its interaction with STAT3 and the implications for vascular remodeling.
  • The studies indicate that disrupting the Hsp110-STAT3 interaction through various inhibitors can offer novel therapeutic strategies for treating PAH.
  • Additionally, Gao explores broader implications of Hsp110, including its potential as a diagnostic and therapeutic target in various diseases and examines care needs within China's elderly care institutions, emphasizing the importance of health assessments.